logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
13/03/2026
Brilliance China Automotive: It is projected that the pre-tax profit audited by 2025 will drop by as much as 50%.
Latest
4 m ago
On March 13th, Apple announced that it will lower the commission rate for the Chinese App Store starting from March 15th. Baidu stated that this adjustment not only responds to the long-standing concerns of Chinese users and developers, but also signals a more open and positive development for the app ecosystem.
5 m ago
JiuDian Pharmaceuticals: After the implementation of centralized purchasing, product prices have decreased, putting certain pressure on profit margins in the short term.
5 m ago
According to the report by the Japan Broadcasting Corporation, Tokyo Electric Power Company stated that there are no abnormalities in the nuclear reactor and there are no safety hazards.
6 m ago
According to the Japan Broadcasting Corporation, Tokyo Electric Power Company stopped the generator of the No. 6 reactor at the Kashiwazaki-Kariwa nuclear power plant after an alert indicated a minor electrical leakage.
6 m ago
Xuantai Pharmaceuticals: Collaborative product Enzalutamide tablets approved by National Medical Products Administration.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.